Four Patients Become Victims of Contaminated Shots at Tennessee VA Facility

Four patients are suffering complications after receiving contaminated injections at Nashville (Tenn.) VA Medical Center, according to a Tennessean report.

The patients were injected with Avastin, a treatment for macular degeneration. A study published in the New England Journal of Medicine this year showed Avastin is a cost-effective alternative to Lucentis, an FDA-approved treatment also for macular degeneration. However, Lucentis costs approximately $2,000, compared to $50 for Avastin, which is not available in single-dose vials, according to the report.

 

Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!



Avastin is not FDA-approved due to that reason, forcing hospital pharmacies to compound the drug for intravenous use, according to the report. Notably, sterility issues stemming from compounding drugs was the subject of a VA advisory bulletin posted in 2006, warning patients of eyeball inflammation due to Avastin injections.

Read the report about contaminated Avastin injections at Nashville VA Medical Center.

Related Articles on Quality:

Connecticut Surgery Center Shuttered Over License Suspension Set to Reopen
Two-Thirds of Illinois Surgery Centers Inspected Cited for Infection Control Problems
CMS Update Reveals Mortality Rates for Heart Failure, Pneumonia; 30-Day Readmission Rates for Heart Attack Slightly Up

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 


Patient Safety Tools & Resources Database

Featured Webinars

Featured Whitepapers

Featured Podcast